Antiosteoporosis effect of bryodulcosigenin on ovariectomy-induced osteoporosis in experimental rats.

Published in: Acta cirurgica brasileira (2024)

Bryodulcosigenin reduced the cytokines level and suppressed the TGF-β and IGF. We concluded that bryodulcosigenin is an antiosteoporosis medication based on the findings.

Keyphrases

high glucose
postmenopausal women
diabetic rats
bone mineral density
transforming growth factor
healthcare
bone loss
drug induced
endothelial cells
binding protein
adverse drug
cell proliferation